Work History

Work History
Mar 2011 - Present

Independent Consultant


Strategy and business development expert for biotech and clean tech industries. Providing services in growth strategy, commercialization, valuation, and business model development/improvement.

Aug 2008 - Sep 2010

Strategy Consultant

The Boston Consulting Group

Consultant at BCG, a global management consulting firm and the world's leading advisor on business strategy, providing analysis, direction, and strategy in corporate development, M&A due diligence, post-merger integration, and performance optimization in the healthcare, biotechnology, and pharmaceutical industries.

Jun 2003 - Aug 2008

Research Associate

The University of Chicago - Marcus Peter Laboratory

Cancer biology researcher studying mechanisms that allow tumors to avoid cell death and activate pro-tumorgenic signaling pathways, particularly the study of microRNA regulation of apoptotic signaling and characterization of non-apoptotic signal activation following CD95/Fas stimulation.

Jan 2004 - Jun 2007

Instructor - Biology and Organic Chemistry

The Princeton Review

Instructed biology and organic chemistry courses on a part-time basis to students in preparation of their Medical College Admissions Test (MCAT).


2003 - 2009


University of Chicago
2001 - 2003


University of California, San Diego


Science, sailing, cycling, sudoku, reading


A Senior Consultant specializing in brand management and business development for Campbell Alliance, the premier management-consulting firm for the pharmaceutical and biotech industries, Robert Schickel, Ph.D., places his strong background in biotechnology and health care at the service of his management clients. Doing business as an independent consultant, Dr. Schickel primarily advises biotech and cleantech companies on growth strategy, valuation, business model development, and commercialization. He combines scientific training with experience in management functions like market research, growth strategy, due diligence for mergers and acquisitions, and postmerger integration. Academically trained in biomedical sciences, Robert Schickel developed his business acumen at the University of Chicago’s Booth School of Business and The Boston Consulting Group (BCG). BCG, the world's leading advisor on business strategy, assigned Schickel to counsel clients in the health care and pharmaceutical industries. For example, his analysis found $80 million in lost revenue due to errors and inefficiencies at one drug manufacturing and distribution company. Dr. Schickel’s consulting services for another pharmaceutical client identified $500 million in savings in selling, generation, and administrative (SG&A) expenses through horizontal integration following a $15 billion merger. Robert Schickel earned his Bachelor of Science in Biochemistry and Chemistry at the University of California, San Diego. He later obtained a Ph.D. in Cancer Biology from the University of Chicago and published articles in professional science and medical journals on the immune system, breast and ovarian cancer, and molecular mechanisms of cell death. While he was at the University of Chicago, the U.S. Department of Defense awarded Robert Schickel a $90,000 fellowship for the purpose of breast cancer research. Outside of his business and science endeavors, Dr. Schickel enjoys the outdoors, sailing, and cycling. He also relaxes by playing Sudoku and reading.